Plunkett Research Online: Morphic Holding Inc

MORPHIC HOLDING INC (MORF:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Morphic Holding, Inc. is a biotechnology company developing oral integrin drugs through its integrin discovery platform, MInT. Integrins are transmembrane receptors that facilitate cell-extracellular matrix adhesion, activating signal transduction pathways that mediate cellular signals. Integrins .....



Morphic Holding Inc
Ticker: MORF
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 781 996-0955
Fax:
Address: 35 Gatehouse Drive, A2
Waltham, MA 02451 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Contacts Description

Praveen Tipirneni CEO/Pres.
Morphic Holding, Inc. is a biotechnology company developing oral integrin drugs through its integrin discovery platform, MInT. Integrins are transmembrane receptors that facilitate cell-extracellular matrix adhesion, activating signal transduction pathways that mediate cellular signals. Integrins .....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
MInt
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: